A detail-oriented collaborator, focused on generating value for customers and shareholders, Paul Fry is Argenta’s CFO. His proven track record and vast experience, combined with his strategic financial expertise and outstanding leadership qualities, help drive long-term growth and scale for Argenta.
Paul has extensive financial experience across several industries including biotech, pharmaceuticals, and telecommunications. His 30+ year career in the human healthcare space started at GSK and continued at Immunocore Limited, a leading biotech company focused on the development of a new class of immunotherapeutic drugs. He then moved to Vectura Group plc as Chief Financial Officer, playing an instrumental role in almost doubling the company’s valuation.
Argenta is Paul’s first professional role in animal health, but he is no stranger to animals at home, thanks to the two British shorthair cats he shares with his family. Paul holds a degree from Oxford University and is a member of the Chartered Institute of Management Accounts.
